跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Timol-P
Approved
STANDARD
Timol-P
Indiana Ophthalmics
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
804c8fb451d96fe6
Company
Indiana Ophthalmics
Type
Standard
Approval Details
Approval Id
804c8fb451d96fe6
Drug Approval Philippines Name
Timol-P
Product Name
Timol-P
Registration Number
DRP-5499-06
Brand Name
Timol-P
Generic Name
Timolol (as Maleate)
Dosage Form
Ophthalmic Solution
Dosage Strength
5 mg/mL (0.5% w/v)
Manufacturer
Indiana Ophthalmics
Trader
Stallion Laboratories Pvt. Ltd
Importer
Ambica International Corporation
Distributor
Ophtha Pharma Traders Inc.
Issuance Date
28 March 2024
Expiry Date
05 September 2029
Pharmacologic Category
Anti-glaucoma (Beta-Adrenoreceptor Blocker)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
804c8fb451d96fe6
Type
Standard
Back to Philippines FDA Approvals